Characteristics of and risk factors for relapse of brucellosis in humans
- PMID: 7620005
- DOI: 10.1093/clinids/20.5.1241
Characteristics of and risk factors for relapse of brucellosis in humans
Abstract
For 16 years we prospectively observed 530 adult patients with brucellosis to analyze the characteristics of and risk factors for relapse. Clinical and laboratory findings from 86 relapsed patients were milder during the relapse episode when compared with those for the same patients during the initial disease. Blood cultures were positive for Brucella melitensis in 65% of cases during relapse and in approximately 80% of cases during the initial disease. Risk factors that were identified as being independently associated with relapse (by logistic regression analysis) were "less-effective" antibiotic therapy (OR, 8.3; 95% CI, 4.6-15.1), positive blood cultures during initial disease (OR, 2.7; 95% CI, 1.2-6.2), < or = 10-day duration of the disease before treatment (OR, 1.9; 95% CI, 1.1-3.6), male sex (OR, 1.8; 95% CI, 1.02-3.8) and a platelet count of < or = 150 x 10(3)/mm3 (OR, 1.7; 95% CI, 1.1-2.8). These data show that relapse of brucellosis is sometimes difficult to diagnose and that it can be an insidious disease. In addition to inappropriate antibiotic therapy, other factors, such as those indicating a more aggressive disease and/or a deficient immunologic response, seem to play an important role in the relapse of brucellosis.
Similar articles
-
Characteristic cutaneous lesions in patients with brucellosis.Arch Dermatol. 1989 Mar;125(3):380-3. Arch Dermatol. 1989. PMID: 2923445
-
Use of real-time quantitative polymerase chain reaction to monitor the evolution of Brucella melitensis DNA load during therapy and post-therapy follow-up in patients with brucellosis.Clin Infect Dis. 2006 May 1;42(9):1266-73. doi: 10.1086/503035. Epub 2006 Mar 31. Clin Infect Dis. 2006. PMID: 16586386
-
Effect of age and duration of disease on the clinical manifestations of brucellosis. A study of 73 consecutive patients in Israel.Isr J Med Sci. 1993 Jan;29(1):11-6. Isr J Med Sci. 1993. PMID: 8454438
-
Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. doi: 10.1007/s00280-002-0447-1. Epub 2002 Apr 12. Cancer Chemother Pharmacol. 2002. PMID: 12042984 Review.
-
Clinical manifestations and complications in 1028 cases of brucellosis: a retrospective evaluation and review of the literature.Int J Infect Dis. 2010 Jun;14(6):e469-78. doi: 10.1016/j.ijid.2009.06.031. Epub 2009 Nov 11. Int J Infect Dis. 2010. PMID: 19910232 Review.
Cited by
-
Clinical manifestations, laboratory findings, and therapeutic regimen in hospitalized children with brucellosis in an Iranian Referral Children Medical Centre.J Health Popul Nutr. 2013 Jun;31(2):218-22. doi: 10.3329/jhpn.v31i2.16386. J Health Popul Nutr. 2013. PMID: 23930340 Free PMC article.
-
Bacteremic and nonbacteremic brucellosis: clinical and laboratory observations.Infection. 2009 Feb;37(1):67-9. doi: 10.1007/s15010-008-7353-3. Epub 2009 Jan 12. Infection. 2009. PMID: 19139815 No abstract available.
-
Brucellosis relapse: Rate, patient characteristics, and clinical outcomes in an endemic region.PLoS Negl Trop Dis. 2025 Jul 7;19(7):e0013270. doi: 10.1371/journal.pntd.0013270. eCollection 2025 Jul. PLoS Negl Trop Dis. 2025. PMID: 40623038 Free PMC article.
-
Reversion of a RND transporter pseudogene uncovers latent stress resistance in Brucella ovis.bioRxiv [Preprint]. 2025 May 10:2025.05.10.653276. doi: 10.1101/2025.05.10.653276. bioRxiv. 2025. Update in: PLoS Genet. 2025 Jul 21;21(7):e1011795. doi: 10.1371/journal.pgen.1011795. PMID: 40655013 Free PMC article. Updated. Preprint.
-
A 26-year-old man with sternoclavicular arthritis.PLoS Med. 2006 Aug;3(8):e293. doi: 10.1371/journal.pmed.0030293. PLoS Med. 2006. PMID: 16942392 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources